These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24258994)

  • 1. Epigenetic markers of prognosis in melanoma.
    Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
    Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
    Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
    J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
    Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
    J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
    Martinez SR; Hoon DS
    J Cell Biochem; 2005 Oct; 96(3):473-83. PubMed ID: 16088931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic change in DNA structure may serve as marker for melanoma.
    Oncology (Williston Park); 2012 Oct; 26(10):930. PubMed ID: 23176003
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
    Wiesner T; Fried I; Cerroni L; Kutzner H
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
    [No Abstract]   [Full Text] [Related]  

  • 7. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
    De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
    Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
    Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.
    Lahtz C; Stranzenbach R; Fiedler E; Helmbold P; Dammann RH
    J Invest Dermatol; 2010 Feb; 130(2):620-2. PubMed ID: 19798057
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation analysis in malignant melanoma.
    Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
    [No Abstract]   [Full Text] [Related]  

  • 11. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long interspersed nucleotide element-1 hypomethylation in canine malignant mucosal melanoma.
    Ishizaki T; Yamazaki J; Meagawa S; Yokoyama N; Aoshima K; Takiguchi M; Kimura T
    Vet Comp Oncol; 2020 Dec; 18(4):854-860. PubMed ID: 32187810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
    Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
    Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic classification of difficult melanocytic tumors.
    Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
    [No Abstract]   [Full Text] [Related]  

  • 16. Update of diagnostic and prognostic markers in cutaneous malignant melanoma.
    Reed JA; Albino AP
    Clin Lab Med; 2000 Dec; 20(4):817-38. PubMed ID: 11221516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers in skin cancer.
    Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
    Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSLC1 gene silencing in cutaneous melanoma.
    You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
    Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.